-
1
المؤلفون: Wengong Chu, Lixing Shu, Gao Shen, Wang Zhuo, Yang Zhangwei, Yangfang Bian, Fei Dai
المصدر: Clinical drug investigation. 33(11)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Perforation (oil well), Absolute risk reduction, Angiogenesis Inhibitors, General Medicine, Number needed to harm, Lower risk, Antibodies, Monoclonal, Humanized, Clinical trial, Internal medicine, Relative risk, Medicine, Humans, Pharmacology (medical), Neoplasm Metastasis, business, Adverse effect, Colorectal Neoplasms, medicine.drug, Randomized Controlled Trials as Topic
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cbdcb1c87946c236bf56dc969d02939Test
https://pubmed.ncbi.nlm.nih.gov/23979925Test -
2دورية أكاديمية
المؤلفون: Dai, Fei, Shu, Lixing, Bian, Yangfang, Wang, Zhuo, Yang, Zhangwei, Chu, Wengong, Gao, Shen
المصدر: Clinical Drug Investigation; Nov2013, Vol. 33 Issue 11, p779-788, 10p
مصطلحات موضوعية: BEVACIZUMAB, MEDICATION safety, COLON cancer treatment, CLINICAL trials, DRUG utilization, META-analysis, SYSTEMATIC reviews